These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 97801)

  • 1. A study of acquired inhibitors of factor IX by means of precipitating rabbit antisera against factor IX.
    Orstavik KH; Nilsson IM
    Thromb Res; 1978 May; 12(5):863-74. PubMed ID: 97801
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of precipitating antisera against normal and abnormal factor IX.
    Orstavik KH
    Thromb Res; 1977 May; 10(5):731-41. PubMed ID: 407667
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization and experimental use of a monospecific antiserum to factor IX.
    Pechet L; Tiarks CY; Chang CH; Sudhindra RR; Lipworth L
    Thromb Haemost; 1979 Feb; 40(3):455-64. PubMed ID: 106483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic studies of factor IX (Christmas factor). I. Counterimmunoelectrophoresis method for factor IX antigen.
    Yang HC
    Thromb Res; 1978 Jul; 13(1):97-109. PubMed ID: 99838
    [No Abstract]   [Full Text] [Related]  

  • 5. Alloantibodies to factor IX in Haemophilia B characterized by crossed immunoelectrophoresis and enzyme-conjugated antisera to human immunoglobulins.
    Orstavik KH
    Br J Haematol; 1981 May; 48(1):15-23. PubMed ID: 6788066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitor-neutralisation assay and electro-immuno assay of human factor IX (Christmas factor).
    Bertina RM; van der Linden IK
    Clin Chim Acta; 1977 Jun; 77(3):275-86. PubMed ID: 559555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electroimmunoassay of factor IX antigen: increased sensitivity by enzyme amplification of immunoprecipitates.
    Orstavik KH
    Thromb Res; 1979; 15(5-6):721-6. PubMed ID: 386558
    [No Abstract]   [Full Text] [Related]  

  • 8. Sensitive solid phase enzyme immunoassay for factor IX antigen and classification of hemophilia B.
    Takamatsu J; Kamiya T; Ogata K; Sugihara T; Koie K; Kato K
    Haemostasis; 1983; 13(1):9-16. PubMed ID: 6341181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of factor IX antigen and coagulant in hemophilia B patients and carriers.
    Pechet L; Tiarks CY; Stevens J; Sudhindra RR; Lipworth L
    Thromb Haemost; 1979 Feb; 40(3):465-77. PubMed ID: 425061
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of an occult inhibitor to factor IX in a haemophilia B patient.
    Miller CH; Orstavik KH; Hilgartner MW
    Br J Haematol; 1985 Oct; 61(2):329-38. PubMed ID: 4041376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG subclass identification of inhibitors to factor IX in haemophilia B patients.
    Orstavik KH; Miller CH
    Br J Haematol; 1988 Apr; 68(4):451-4. PubMed ID: 3377985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor IX alloantibodies shorten the bovine thromboplastin coagulation time of normal human plasma.
    Orstavik KH
    Thromb Haemost; 1981 Dec; 46(4):684-6. PubMed ID: 7330818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological heterogeneity of haemophilia B: a multicentre study of 98 kindreds.
    Parekh VR; Mannucci PM; Ruggeri ZM
    Br J Haematol; 1978 Dec; 40(4):643-55. PubMed ID: 103564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor IX in warfarin treated patients.
    Orstavik KH; Laake K
    Thromb Res; 1978 Aug; 13(2):207-18. PubMed ID: 694840
    [No Abstract]   [Full Text] [Related]  

  • 15. Heterogeneity of factor IX in therapeutic factor IX concentrates.
    Menache D; Aronson DL
    Thromb Res; 1978 Nov; 13(5):821-8. PubMed ID: 741455
    [No Abstract]   [Full Text] [Related]  

  • 16. Spontaneous disappearance of an IgA anti-factor IX inhibitor in a child with Christmas disease.
    Carroll RR; Panush RS; Kitchens CS
    Am J Hematol; 1984 Oct; 17(3):321-5. PubMed ID: 6475941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on Christmas disease: investigation and treatment of a familial acquired inhibitor of factor IX.
    George JN; Miller GM; Breckenridge RT
    Br J Haematol; 1971 Sep; 21(3):333-42. PubMed ID: 4998792
    [No Abstract]   [Full Text] [Related]  

  • 18. Factor IX antigen by radioimmunoassay. Abnormal factor IX protein in patients on warfarin therapy and with hemophilia B.
    Thompson AR
    J Clin Invest; 1977 May; 59(5):900-10. PubMed ID: 856873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laurell crossed immunoelectrophoresis and affinity chromatography for the purification of a parasite antigen.
    Hillyer GV; Cervoni M
    J Immunol Methods; 1978; 20():385-90. PubMed ID: 418120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The abnormal factor IX of hemophilia B+ variants.
    Bertina RM; Veltkamp JJ
    Thromb Haemost; 1978 Oct; 40(2):335-49. PubMed ID: 734633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.